Yüklüyor......
Beyond the Time Window of Intravenous Thrombolysis: Standing by or by Stenting?
Intravenous administration of tissue plasminogen activator within 4.5 h of symptom onset is presently the ‘golden rule’ for treating acute ischemic stroke. However, many patients miss the time window and others reject this treatment due to a long list of contraindications. Mechanical embolectomy has...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
S. Karger AG
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4031767/ https://ncbi.nlm.nih.gov/pubmed/25187761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000338389 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|